Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coherus Oncology (CHRS) Tax Rate: 2019-2023

Historic Tax Rate for Coherus Oncology (CHRS) over the last 2 years, with Sep 2023 value amounting to 0.95%.

  • Coherus Oncology's Tax Rate was N/A to 0.95% in Q3 2023 from the same period last year, while for Dec 2020 it was 2.60%, marking a year-over-year change of. This contributed to the annual value of 0.16% for FY2023, which is N/A change from last year.
  • Per Coherus Oncology's latest filing, its Tax Rate stood at 0.95% for Q3 2023, which was down 90.62% from 10.12% recorded in Q4 2020.
  • In the past 5 years, Coherus Oncology's Tax Rate ranged from a high of 10.12% in Q4 2020 and a low of 0.22% during Q2 2019.
  • Moreover, its 1-year median value for Tax Rate was 0.95% (2023), whereas its average is 0.95%.
  • Within the past 5 years, the most significant YoY rise in Coherus Oncology's Tax Rate was 517bps (2020), while the steepest drop was 106bps (2020).
  • Coherus Oncology's Tax Rate (Quarterly) stood at 4.95% in 2019, then surged by 517bps to 10.12% in 2020, then reached 0.95% in 2023.
  • Its last three reported values are 0.95% in Q3 2023, 10.12% for Q4 2020, and 0.71% during Q3 2020.